Cargando…

Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users

Objectives. A once-daily, extended-release hydrocodone bitartrate tablet with abuse-deterrent properties (Hysingla ER® [HYD]) is available for the treatment of chronic pain in appropriate patients. This study evaluated the intranasal abuse potential and pharmacokinetics of HYD coarse and fine partic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, Stephen C., Cipriano, Alessandra, Colucci, Salvatore V., Kapil, Ram P., Geoffroy, Pierre, Hopyan, Talar, Levy-Cooperman, Naama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	GENERAL SECTION
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984427/ https://www.ncbi.nlm.nih.gov/pubmed/26814240 http://dx.doi.org/10.1093/pm/pnv004

Ejemplares similares

Oral Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users
por: Harris, Stephen C., et al.
Publicado: (2017)

Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users
por: Bond, Mary, et al.
Publicado: (2018)

Relative Bioavailability, Intranasal Abuse Potential, and Safety of Benzhydrocodone/Acetaminophen Compared with Hydrocodone Bitartrate/Acetaminophen in Recreational Drug Abusers
por: Guenther, Sven M, et al.
Publicado: (2018)

Pharmacokinetics and Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone, After Intranasal Administration in Recreational Drug Users
por: Mickle, Travis C, et al.
Publicado: (2018)

Abuse Potential with Oral Route of Administration of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users
por: Darwish, Mona, et al.
Publicado: (2017)

Abuse potential of mirogabalin in recreational polydrug users
por: Mendell, Jeanne, et al.
Publicado: (2019)

Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recreational Opioid Users
por: Setnik, Beatrice, et al.
Publicado: (2017)

Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users
por: Harris, Stephen C, et al.
Publicado: (2014)

No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial
por: Seifritz, Erich, et al.
Publicado: (2020)

Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist
por: Levy-Cooperman, N., et al.
Publicado: (2016)

Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone
por: Ben-Joseph, Rami, et al.
Publicado: (2016)

Patterns of abuse and routes of administration for immediate‐release hydrocodone combination products
por: Cassidy, Theresa A., et al.
Publicado: (2017)

Real-world utilization of once-daily extended-release abuse deterrent formulation of hydrocodone: a comparison with the pre-approval randomized clinical trials
por: Taber, Louise, et al.
Publicado: (2017)

Biosynthesis of the catalytic H-cluster of [FeFe] hydrogenase: the roles of the Fe–S maturase proteins HydE, HydF, and HydG
por: Britt, R. David, et al.
Publicado: (2020)

Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone
por: Weiner, Scott G., et al.
Publicado: (2022)

Use of Hyd. Potass. in Hydrocephalus
por: Mead, Thompson
Publicado: (1847)

Effectiveness and Safety of Once-Daily Extended-Release Hydrocodone in Individuals Previously Receiving Immediate-Release Oxycodone for Chronic Pain
por: Pergolizzi, Joseph, et al.
Publicado: (2018)

Extended-release hydrocodone – gift or curse?
por: Krashin, Daniel, et al.
Publicado: (2013)

Quantification of Opioid Prescription Practice Changes Due to Hydrocodone Combination Product Rescheduling in an Academic Pain Clinic
por: Ngo, John, et al.
Publicado: (2020)

Oral Human Abuse Potential of Oxycodone DETERx(®) (Xtampza(®) ER)
por: Kopecky, Ernest A., et al.
Publicado: (2016)

Clinical profile and outcomes of opioid abuse gastroenteropathy: an underdiagnosed disease entity
por: Mahajan, Ramit, et al.
Publicado: (2020)

Hydrocodone, Oxycodone, and Morphine Metabolism and Drug–Drug Interactions
por: Coates, Shelby, et al.
Publicado: (2023)

Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) vs Extended-Release Morphine Administered Intranasally in Nondependent Recreational Opioid Users
por: Webster, Lynn R., et al.
Publicado: (2017)

Abuse Potential of Intravenous Oxycodone/Naloxone Solution in Nondependent Recreational Drug Users
por: Colucci, Salvatore V., et al.
Publicado: (2014)

Assessment of Alcohol-Induced Dose Dumping with a Hydrocodone Bitartrate Extended-Release Tablet Formulated with CIMA(®) Abuse Deterrence Technology
por: Darwish, Mona, et al.
Publicado: (2015)

Proposed Mechanism for the Biosynthesis of the [FeFe] Hydrogenase H-Cluster: Central Roles for the Radical SAM Enzymes HydG and HydE
por: Britt, R. David, et al.
Publicado: (2021)

A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough
por: Sloan, Victor S., et al.
Publicado: (2019)

A Case of Traumatic Tetanus, Treated with Hyd. Chloral
por: Kinnear, A. H.
Publicado: (1870)

A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain
por: Nalamachu, Srinivas, et al.
Publicado: (2014)

HydDB: A web tool for hydrogenase classification and analysis
por: Søndergaard, Dan, et al.
Publicado: (2016)

A Case of Poisoning with Morphia and Hyd. Chloral—Remarkable Recovery
por: Griffin, Theodore
Publicado: (1872)

Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users
por: Shram, Megan J., et al.
Publicado: (2021)

Androgen Abuse among Recreational Athletes
por: Araujo, Maíta Poli de
Publicado: (2019)

Prolonged Ventricular Asystole: A Rare Adverse Effect of Hydrocodone Use
por: Sudhakaran, Sivakumar, et al.
Publicado: (2014)

Critical appraisal of extended-release hydrocodone for chronic pain: patient considerations
por: Gould, Harry J, et al.
Publicado: (2015)

Preclinical and Clinical Pharmacology of Hydrocodone for Chronic Pain: A Mini Review
por: Cardia, Luigi, et al.
Publicado: (2018)

Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study
por: Göhler, Karin, et al.
Publicado: (2019)

Cellular Uptake and Antitumor Activity of DOX-hyd-PEG-FA Nanoparticles
por: Ye, Wei-liang, et al.
Publicado: (2014)

Effect of opioid dependence or abuse on opioid utilization after shoulder arthroplasty
por: Berglund, Derek D, et al.
Publicado: (2018)

Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
por: Ayoub, Bassam M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vgpb5u3uf5nsuhdp021ds6qs37